APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Disease Detection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Disease Detection Market Outlook and Growth Opportunities 2026

4 March 2026209 pages

Choose your research edition.

Industry ResearchAI Disease Detection Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Disease Detection Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal AI Disease Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Disease Detection Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Disease Detection Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global AI Disease Detection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Disease Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Disease Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Disease Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Disease Detection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Disease Detection market include Nuvoola, Oatmeal Health, NIRAMAI, iCAD, MultiplAI Health, Medicus AI, AEYE Health, NURA and Kheiron, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Disease Detection market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Disease Detection and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Disease Detection revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Disease Detection market.

AI Disease Detection Segment by Company

Nuvoola

Oatmeal Health

NIRAMAI

iCAD

MultiplAI Health

Medicus AI

AEYE Health

NURA

Kheiron

Aidoc

Aiberry

Ellipsis Health

Omdena

Innowise Group

Syndell

Klizo Solutions

Wysa

AI Disease Detection Segment by Type

Physical Ailment

Mental Illness

AI Disease Detection Segment by Application

Hospital

Enterprise

Individual

Others

AI Disease Detection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Disease Detection status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Disease Detection key companies, revenue, market share, and recent developments.

3. To split the AI Disease Detection breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Disease Detection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Disease Detection significant trends, drivers, influence factors in global and regions.

6. To analyze AI Disease Detection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Disease Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Disease Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Disease Detection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Disease Detection industry.

Chapter 3: Detailed analysis of AI Disease Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Disease Detection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Disease Detection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Disease Detection Industry Trends Table 2. AI Disease Detection Industry Drivers Table 3. AI Disease Detection Industry Opportunities and Challenges Table 4. AI Disease Detection Industry Restraints Table 5. Global AI Disease Detection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Disease Detection Revenue Share by Company (2021-2026) Table 7. Global AI Disease Detection Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Disease Detection Key Company Manufacturing Base & Headquarters Table 9. Global AI Disease Detection Company, Product Type & Application Table 10. Global AI Disease Detection Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Disease Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Physical Ailment Table 15. Significant Companies of Mental Illness Table 16. Global AI Disease Detection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI Disease Detection Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI Disease Detection Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI Disease Detection Sales Value Share by Type (2021-2026) Table 20. Global AI Disease Detection Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Enterprise Table 23. Significant Companies of Individual Table 24. Significant Companies of Others Table 25. Global AI Disease Detection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI Disease Detection Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global AI Disease Detection Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global AI Disease Detection Sales Value Share by Application (2021-2026) Table 29. Global AI Disease Detection Sales Value Share by Application (2027-2032) Table 30. Global AI Disease Detection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Disease Detection Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global AI Disease Detection Sales Value Share by Region (2021-2026) Table 33. Global AI Disease Detection Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global AI Disease Detection Sales Value Share by Region (2027-2032) Table 35. Global AI Disease Detection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI Disease Detection Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global AI Disease Detection Sales Value Market Share by Country (2021-2026) Table 38. Global AI Disease Detection Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global AI Disease Detection Sales Value Market Share by Country (2027-2032) Table 40. Nuvoola Company Information Table 41. Nuvoola Business Overview Table 42. Nuvoola AI Disease Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Nuvoola AI Disease Detection Product Portfolio Table 44. Nuvoola Recent Development Table 45. Oatmeal Health Company Information Table 46. Oatmeal Health Business Overview Table 47. Oatmeal Health AI Disease Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Oatmeal Health AI Disease Detection Product Portfolio Table 49. Oatmeal Health Recent Development Table 50. NIRAMAI Company Information Table 51. NIRAMAI Business Overview Table 52. NIRAMAI AI Disease Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. NIRAMAI AI Disease Detection Product Portfolio Table 54. NIRAMAI Recent Development Table 55. iCAD Company Information Table 56. iCAD Business Overview Table 57. iCAD AI Disease Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. iCAD AI Disease Detection Product Portfolio Table 59. iCAD Recent Development Table 60. MultiplAI Health Company Information Table 61. MultiplAI Health Business Overview Table 62. MultiplAI Health AI Disease Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. MultiplAI Health AI Disease Detection Product Portfolio Table 64. MultiplAI Health Recent Development Table 65. Medicus AI Company Information Table 66. Medicus AI Business Overview Table 67. Medicus AI AI Disease Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Medicus AI AI Disease Detection Product Portfolio Table 69. Medicus AI Recent Development Table 70. AEYE Health Company Information Table 71. AEYE Health Business Overview Table 72. AEYE Health AI Disease Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. AEYE Health AI Disease Detection Product Portfolio Table 74. AEYE Health Recent Development Table 75. NURA Company Information Table 76. NURA Business Overview Table 77. NURA AI Disease Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. NURA AI Disease Detection Product Portfolio Table 79. NURA Recent Development Table 80. Kheiron Company Information Table 81. Kheiron Business Overview Table 82. Kheiron AI Disease Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Kheiron AI Disease Detection Product Portfolio Table 84. Kheiron Recent Development Table 85. Aidoc Company Information Table 86. Aidoc Business Overview Table 87. Aidoc AI Disease Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Aidoc AI Disease Detection Product Portfolio Table 89. Aidoc Recent Development Table 90. Aiberry Company Information Table 91. Aiberry Business Overview Table 92. Aiberry AI Disease Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Aiberry AI Disease Detection Product Portfolio Table 94. Aiberry Recent Development Table 95. Ellipsis Health Company Information Table 96. Ellipsis Health Business Overview Table 97. Ellipsis Health AI Disease Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Ellipsis Health AI Disease Detection Product Portfolio Table 99. Ellipsis Health Recent Development Table 100. Omdena Company Information Table 101. Omdena Business Overview Table 102. Omdena AI Disease Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Omdena AI Disease Detection Product Portfolio Table 104. Omdena Recent Development Table 105. Innowise Group Company Information Table 106. Innowise Group Business Overview Table 107. Innowise Group AI Disease Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Innowise Group AI Disease Detection Product Portfolio Table 109. Innowise Group Recent Development Table 110. Syndell Company Information Table 111. Syndell Business Overview Table 112. Syndell AI Disease Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Syndell AI Disease Detection Product Portfolio Table 114. Syndell Recent Development Table 115. Klizo Solutions Company Information Table 116. Klizo Solutions Business Overview Table 117. Klizo Solutions AI Disease Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Klizo Solutions AI Disease Detection Product Portfolio Table 119. Klizo Solutions Recent Development Table 120. Wysa Company Information Table 121. Wysa Business Overview Table 122. Wysa AI Disease Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Wysa AI Disease Detection Product Portfolio Table 124. Wysa Recent Development Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. AI Disease Detection Product Image Figure 2. Global AI Disease Detection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Disease Detection Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Disease Detection Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Physical Ailment Image Figure 8. Mental Illness Image Figure 9. Global AI Disease Detection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI Disease Detection Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI Disease Detection Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Enterprise Image Figure 14. Individual Image Figure 15. Others Image Figure 16. Global AI Disease Detection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global AI Disease Detection Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global AI Disease Detection Sales Value Share by Application (2021-2032) Figure 19. Global AI Disease Detection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global AI Disease Detection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America AI Disease Detection Sales Value (2021-2032) & (US$ Million) Figure 22. North America AI Disease Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe AI Disease Detection Sales Value (2021-2032) & (US$ Million) Figure 24. Europe AI Disease Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific AI Disease Detection Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific AI Disease Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America AI Disease Detection Sales Value (2021-2032) & (US$ Million) Figure 28. South America AI Disease Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa AI Disease Detection Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa AI Disease Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt AI Disease Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt AI Disease Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt AI Disease Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Physical Ailment
  • Mental Illness
Applications
  • Hospital
  • Enterprise
  • Individual
  • Others
Companies covered
  • Nuvoola
  • Oatmeal Health
  • NIRAMAI
  • iCAD
  • MultiplAI Health
  • Medicus AI
  • AEYE Health
  • NURA
  • Kheiron
  • Aidoc
  • Aiberry
  • Ellipsis Health
  • Omdena
  • Innowise Group
  • Syndell
  • Klizo Solutions
  • Wysa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Disease Detection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Disease Detection Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Disease Detection Market Dynamics
  1. 2.1 AI Disease Detection Industry Trends
  2. 2.2 AI Disease Detection Industry Drivers
  3. 2.3 AI Disease Detection Industry Opportunities and Challenges
  4. 2.4 AI Disease Detection Industry Restraints
3 AI Disease Detection Market by Company
  1. 3.1 Global AI Disease Detection Company Revenue Ranking in 2025
  2. 3.2 Global AI Disease Detection Revenue by Company (2021-2026)
  3. 3.3 Global AI Disease Detection Company Ranking (2024-2026)
  4. 3.4 Global AI Disease Detection Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Disease Detection Company Product Type and Application
  6. 3.6 Global AI Disease Detection Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Disease Detection Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Disease Detection Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Disease Detection Market by Type
  1. 4.1 AI Disease Detection Type Introduction
  2. 4.1.1 Physical Ailment
  3. 4.1.2 Mental Illness
  4. 4.2 Global AI Disease Detection Sales Value by Type
  5. 4.2.1 Global AI Disease Detection Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI Disease Detection Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI Disease Detection Sales Value Share by Type (2021-2032)
5 AI Disease Detection Market by Application
  1. 5.1 AI Disease Detection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Enterprise
  4. 5.1.3 Individual
  5. 5.1.4 Others
  6. 5.2 Global AI Disease Detection Sales Value by Application
  7. 5.2.1 Global AI Disease Detection Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global AI Disease Detection Sales Value by Application (2021-2032)
  9. 5.2.3 Global AI Disease Detection Sales Value Share by Application (2021-2032)
6 AI Disease Detection Regional Value Analysis
  1. 6.1 Global AI Disease Detection Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Disease Detection Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Disease Detection Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Disease Detection Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Disease Detection Sales Value (2021-2032)
  7. 6.3.2 North America AI Disease Detection Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Disease Detection Sales Value (2021-2032)
  10. 6.4.2 Europe AI Disease Detection Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Disease Detection Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Disease Detection Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Disease Detection Sales Value (2021-2032)
  16. 6.6.2 South America AI Disease Detection Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Disease Detection Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Disease Detection Sales Value Share by Country, 2025 VS 2032
7 AI Disease Detection Country-level Value Analysis
  1. 7.1 Global AI Disease Detection Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Disease Detection Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Disease Detection Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Disease Detection Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Disease Detection Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Disease Detection Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Disease Detection Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Disease Detection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Disease Detection Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Disease Detection Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Disease Detection Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Disease Detection Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Disease Detection Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Disease Detection Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Disease Detection Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Disease Detection Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Disease Detection Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Disease Detection Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Disease Detection Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Disease Detection Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Disease Detection Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Disease Detection Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Disease Detection Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Disease Detection Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Disease Detection Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Disease Detection Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Disease Detection Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Disease Detection Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Disease Detection Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Disease Detection Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Disease Detection Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Disease Detection Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Disease Detection Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Disease Detection Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Disease Detection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Nuvoola
  2. 8.1.1 Nuvoola Company Information
  3. 8.1.2 Nuvoola Business Overview
  4. 8.1.3 Nuvoola AI Disease Detection Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Nuvoola AI Disease Detection Product Portfolio
  6. 8.1.5 Nuvoola Recent Developments
  7. 8.2 Oatmeal Health
  8. 8.2.1 Oatmeal Health Company Information
  9. 8.2.2 Oatmeal Health Business Overview
  10. 8.2.3 Oatmeal Health AI Disease Detection Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Oatmeal Health AI Disease Detection Product Portfolio
  12. 8.2.5 Oatmeal Health Recent Developments
  13. 8.3 NIRAMAI
  14. 8.3.1 NIRAMAI Company Information
  15. 8.3.2 NIRAMAI Business Overview
  16. 8.3.3 NIRAMAI AI Disease Detection Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NIRAMAI AI Disease Detection Product Portfolio
  18. 8.3.5 NIRAMAI Recent Developments
  19. 8.4 iCAD
  20. 8.4.1 iCAD Company Information
  21. 8.4.2 iCAD Business Overview
  22. 8.4.3 iCAD AI Disease Detection Revenue and Gross Margin (2021-2026)
  23. 8.4.4 iCAD AI Disease Detection Product Portfolio
  24. 8.4.5 iCAD Recent Developments
  25. 8.5 MultiplAI Health
  26. 8.5.1 MultiplAI Health Company Information
  27. 8.5.2 MultiplAI Health Business Overview
  28. 8.5.3 MultiplAI Health AI Disease Detection Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MultiplAI Health AI Disease Detection Product Portfolio
  30. 8.5.5 MultiplAI Health Recent Developments
  31. 8.6 Medicus AI
  32. 8.6.1 Medicus AI Company Information
  33. 8.6.2 Medicus AI Business Overview
  34. 8.6.3 Medicus AI AI Disease Detection Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medicus AI AI Disease Detection Product Portfolio
  36. 8.6.5 Medicus AI Recent Developments
  37. 8.7 AEYE Health
  38. 8.7.1 AEYE Health Company Information
  39. 8.7.2 AEYE Health Business Overview
  40. 8.7.3 AEYE Health AI Disease Detection Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AEYE Health AI Disease Detection Product Portfolio
  42. 8.7.5 AEYE Health Recent Developments
  43. 8.8 NURA
  44. 8.8.1 NURA Company Information
  45. 8.8.2 NURA Business Overview
  46. 8.8.3 NURA AI Disease Detection Revenue and Gross Margin (2021-2026)
  47. 8.8.4 NURA AI Disease Detection Product Portfolio
  48. 8.8.5 NURA Recent Developments
  49. 8.9 Kheiron
  50. 8.9.1 Kheiron Company Information
  51. 8.9.2 Kheiron Business Overview
  52. 8.9.3 Kheiron AI Disease Detection Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kheiron AI Disease Detection Product Portfolio
  54. 8.9.5 Kheiron Recent Developments
  55. 8.10 Aidoc
  56. 8.10.1 Aidoc Company Information
  57. 8.10.2 Aidoc Business Overview
  58. 8.10.3 Aidoc AI Disease Detection Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aidoc AI Disease Detection Product Portfolio
  60. 8.10.5 Aidoc Recent Developments
  61. 8.11 Aiberry
  62. 8.11.1 Aiberry Company Information
  63. 8.11.2 Aiberry Business Overview
  64. 8.11.3 Aiberry AI Disease Detection Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Aiberry AI Disease Detection Product Portfolio
  66. 8.11.5 Aiberry Recent Developments
  67. 8.12 Ellipsis Health
  68. 8.12.1 Ellipsis Health Company Information
  69. 8.12.2 Ellipsis Health Business Overview
  70. 8.12.3 Ellipsis Health AI Disease Detection Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ellipsis Health AI Disease Detection Product Portfolio
  72. 8.12.5 Ellipsis Health Recent Developments
  73. 8.13 Omdena
  74. 8.13.1 Omdena Company Information
  75. 8.13.2 Omdena Business Overview
  76. 8.13.3 Omdena AI Disease Detection Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Omdena AI Disease Detection Product Portfolio
  78. 8.13.5 Omdena Recent Developments
  79. 8.14 Innowise Group
  80. 8.14.1 Innowise Group Company Information
  81. 8.14.2 Innowise Group Business Overview
  82. 8.14.3 Innowise Group AI Disease Detection Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Innowise Group AI Disease Detection Product Portfolio
  84. 8.14.5 Innowise Group Recent Developments
  85. 8.15 Syndell
  86. 8.15.1 Syndell Company Information
  87. 8.15.2 Syndell Business Overview
  88. 8.15.3 Syndell AI Disease Detection Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Syndell AI Disease Detection Product Portfolio
  90. 8.15.5 Syndell Recent Developments
  91. 8.16 Klizo Solutions
  92. 8.16.1 Klizo Solutions Company Information
  93. 8.16.2 Klizo Solutions Business Overview
  94. 8.16.3 Klizo Solutions AI Disease Detection Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Klizo Solutions AI Disease Detection Product Portfolio
  96. 8.16.5 Klizo Solutions Recent Developments
  97. 8.17 Wysa
  98. 8.17.1 Wysa Company Information
  99. 8.17.2 Wysa Business Overview
  100. 8.17.3 Wysa AI Disease Detection Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Wysa AI Disease Detection Product Portfolio
  102. 8.17.5 Wysa Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst